Cargando…

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)

Detalles Bibliográficos
Autores principales:	Kurzawski, G, Dymerska, D, Suchy, J, Dębniak, T, Lubiński, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287433/ http://dx.doi.org/10.1186/1897-4287-10-S1-A13

Ejemplares similares

Lynch syndrome mutations in Poland and the Baltic States
por: Dymerska, Dagmara, et al.
Publicado: (2015)

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients
por: Dymerska, D, et al.
Publicado: (2011)

MSH2 and MLH1 testing
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Principles of genetic predisposition to malignancies
por: Dębniak, Tadeusz, et al.
Publicado: (2008)

Cumulative small effect genetic markers and the detection of advanced colorectal neoplasias by population screening
por: Kurlapska, A, et al.
Publicado: (2012)

DNA testing for variants conferring low or moderate increase in the risk of cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2008)

Diagnostic microarray test for a genetic predisposition to hereditary nonpolyposis colorectal cancer (HNPCC)
por: Kaszuba, M, et al.
Publicado: (2012)

DNA and RNA analyses in detection of genetic predisposition to cancer
por: Kurzawski, Grzegorz, et al.
Publicado: (2012)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

Cancer Predisposition Genes in Cancer-Free Families
por: Zheng, Guoqiao, et al.
Publicado: (2020)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

The PIRO concept: P is for predisposition
por: Angus, Derek C, et al.
Publicado: (2003)

Serum concentration of iron as predictor of cancer risk among BRCA1 mutation carriers
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Functional in silico analysis of missense mutations in the MSH6 gene
por: Gajdel, Katarzyna, et al.
Publicado: (2015)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Magnesium as a diagnostic marker of cancer
por: Marciniak, Wojciech, et al.
Publicado: (2015)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Selenium as diagnostic marker of cancers
por: Jaworska-Bieniek, Katarzyna, et al.
Publicado: (2015)

Zinc as diagnostic marker of cancers
por: Kaczmarek, Katarzyna, et al.
Publicado: (2015)

Iron as diagnostic marker of cancer
por: Sukiennicki, Grzegorz, et al.
Publicado: (2015)

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
por: Dębniak, Tadeusz, et al.
Publicado: (2015)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016
por: Cybulski, C., et al.
Publicado: (2017)

Rapid workflow of mMR PET list-mode data processing using CUDA
por: Markiewicz, Pawel, et al.
Publicado: (2015)

Image reconstruction of mMR PET data using the open source software STIR
por: Markiewicz, Pawel, et al.
Publicado: (2014)

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
por: Gronwald, J, et al.
Publicado: (2009)

DNA and RNA analyses in detection of genetic predisposition to cancer
por: Matyjasik, Joanna, et al.
Publicado: (2008)

Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome
por: Sobocińska, Joanna, et al.
Publicado: (2020)

Some Molecular and Clinical Aspects of Genetic Predisposition to Malignant Melanoma and Tumours of Various Site of Origin
por: Dębniak, Tadeusz
Publicado: (2007)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

EMQN Best Practice guidelines for diagnostic testing of mutations causing non-syndromic hearing impairment at the DFNB1 locus
por: Hoefsloot, Lies H, et al.
Publicado: (2013)

Application of a fast and cost-effective ‘three-in-one’ MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience
por: Böröcz, K., et al.
Publicado: (2020)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
por: Byrski, T, et al.
Publicado: (2012)

Recurrent somatic mutations and low germline predisposition mutations in Korean ALL patients
por: Shin, Sang-Yong, et al.
Publicado: (2021)

Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012)

Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population
por: Paszkowska-Szczur, Katarzyna, et al.
Publicado: (2014)

From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes
por: MacGregor, S, et al.
Publicado: (2012)

Cross calibration of the Siemens mMR: easily acquired accurate PET phantom measurements, long term stability and reproducibility
por: Keller, Sune H, et al.
Publicado: (2015)

New diagnostic test for high risk of breast cancer in Poland
por: Gorski, B
Publicado: (2011)

DNA bank for Polish patients with predispositions to occurrence of colorectal polyposis
por: Pławski, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u5k41jtn30dtvagt1a9sg4d2ls